This topic contains a solution. Click here to go to the answer

Author Question: In a price leadership oligopoly model, a. a cartel of leading firms determines price and industry ... (Read 61 times)

jazziefee

  • Hero Member
  • *****
  • Posts: 505
In a price leadership oligopoly model,
 a. a cartel of leading firms determines price and industry output.
  b. the industry in consortium with the government determines price and output.
  c. one firm is the price leader and all other firms follow.
  d. the firms abandon a profit-maximizing goal.
  e. firms do not operate where MR = MC.

Question 2

Which of the following is an implication of the law of diminishing returns?
 a. Total output will decline as more workers are hired.
  b. In the long run, average total cost will eventually decline as output is expanded.
  c. In the short run, expansion of output will eventually lead to increases in marginal cost and average total cost.
  d. A doubling of all inputs will lead to more than a doubling of output.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

T4T

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

c

Answer to Question 2

c




jazziefee

  • Member
  • Posts: 505
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library